Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 2,429 | 2,817 | 2,632 | 1,661 | 1,026 |
| Gross Profit | 2,429 | 2,817 | 2,632 | 1,661 | 1,026 |
| Operating Expenses | 29,548 | 26,901 | 23,078 | 18,402 | 17,718 |
| Operating Income | -27,119 | -24,084 | -20,446 | -16,741 | -16,692 |
| Interest Expense | 400 | 409 | 405 | 430 | 429 |
| Other Income | 910 | 1,015 | 1,091 | 1,144 | 339 |
| Pre-tax Income | -26,609 | -23,478 | -19,760 | -16,027 | -16,782 |
| Net Income Continuous | -26,609 | -23,478 | -19,760 | -16,027 | -16,782 |
| Net Income | $-26,609 | $-23,478 | $-19,760 | $-16,027 | $-16,782 |
| EPS Basic Total Ops | -0.40 | -0.36 | -0.30 | -0.24 | -0.31 |
| EPS Basic Continuous Ops | -0.40 | -0.36 | -0.30 | -0.24 | -0.31 |
| EPS Diluted Total Ops | -0.40 | -0.36 | -0.30 | -0.24 | -0.31 |
| EPS Diluted Continuous Ops | -0.40 | -0.36 | -0.30 | -0.24 | -0.31 |
| EBITDA(a) | $-26,610 | $-23,658 | $-19,889 | $-16,389 | $-16,450 |